No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
142 |
4. Check minimum number of eventsNone |
142 |
5. Include endpointsNone |
142 |
6. Filter based on genotype QC (FinnGen only) |
142 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_URINARY_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[0-4]
- Name in latin
- Aliae malformationes congenitae renis
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of kidney
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the urinary system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1596 | 808 | 785 |
| Only index persons | 1208 | 636 | 572 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 9.78 | 12.50 | 6.90 |
| Only index persons | 20.45 | 23.76 | 16.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 142 | 89 | 53 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 42.84 | 42.65 | 43.16 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 124
- Matched controls
- 1240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q63.1
ICD-10 Finland
Lobulated, fused and horseshoe kidney
+∞
54.2
48
*
Q63.2
ICD-10 Finland
Ectopic kidney
+∞
37.4
34
*
Q63.9
ICD-10 Finland
Congenital malformation of kidney, unspecified
+∞
22.6
21
*
Q63.88
ICD-10 Finland
Other specified congenital malformations of kidney
+∞
18.2
17
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
11.0
13.6
26
29
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
39.1
11.5
14
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
+∞
10.6
10
*
UKC02
NOMESCO Finland
Cystoscopy
5.3
10.5
34
82
N18.8
ICD-10 Finland
Other chronic renal failure
28.7
10.0
13
5
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
12.9
9.9
17
15
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
+∞
9.5
9
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
20.5
9.1
13
7
A12AA04
ATC
calcium carbonate; oral
29.9
8.6
11
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
29.9
8.6
11
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
96.3
8.5
9
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
48.1
7.8
9
*
N18.0
ICD-10 Finland
End-stage renal disease
48.1
7.8
9
*
A11CC03
ATC
alfacalcidol; systemic
19.9
7.8
11
6
KA1FN
NOMESCO Finland
Isotope renography
85.0
7.5
8
*
Q63.0
ICD-10 Finland
Accessory kidney
+∞
7.4
7
*
TK800
NOMESCO Finland
Hemodialysis
21.6
7.3
10
5
Z49.1
ICD-10 Finland
Extracorporeal dialysis
32.1
7.3
9
*
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
19.2
6.4
9
5
Q63.81
ICD-10 Finland
Congenital diverticulum in renal cup
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
41
114
4.65
14.10
19.7
12.6
mmol/l
10.2
7.3
1.70
41
108
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
26
66
4.59
9.82
9.1
18.1
mg/l
1.4
1.2
0.48
26
61
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
17
8.31
9.43
7.2
5.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
31
6.09
9.21
3.2
19.0
u/ml
0.2
0.4
—
5
19
(3002582) Erythrocytes [#/volume] in Urine
68
375
2.56
6.96
9.3
3.6
e6/l
42.2
47.6
0.07
59
285
(3023368) Bacteria identified in Blood by Culture
51
254
2.57
6.36
6.7
4.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
72
421
2.44
6.35
8.7
3.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
87
561
2.42
6.07
16.5
9.4
mmol/l
1.2
1.2
0.90
81
490
(3018095) Leukocytes [#/volume] in Urine
73
442
2.34
5.80
10.8
4.4
e6/l
56.3
41.4
0.22
62
297
(3030467) Casts [#/volume] in Urine by Automated count
60
345
2.28
5.27
8.8
3.4
e6/l
0.2
0.4
0.77
51
253
(1616796) Gas panel - Central venous blood
11
23
5.10
5.10
8.2
4.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
56
319
2.25
4.98
4.2
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
41
208
2.36
4.75
6.8
3.4
e6/l
1.5
2.8
0.69
29
115
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
76
3.07
4.68
3.6
3.1
ml/min/173m2
66.4
67.5
0.05
13
30
(3009508) Creatinine [Moles/volume] in Urine
54
315
2.15
4.44
6.0
3.5
mmol/l
5.8
7.6
3.00
44
265
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
93
2.76
4.22
3.2
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
47
268
2.12
4.04
7.7
3.8
mg/mmol
24.3
16.4
0.36
31
153
(3023520) Reticulocytes [#/volume] in Blood
22
89
2.74
4.03
2.8
4.1
e9/l
52.9
72.5
1.47
14
67
(36304419) Bacteria [Presence] in Urine
56
342
2.05
4.01
9.0
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
30
143
2.39
3.94
13.9
10.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
31
151
2.35
3.88
2.3
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
52
322
1.97
3.50
11.4
4.2
ph
7.4
7.4
3.07
13
54
(3015377) Calcium [Moles/volume] in Serum or Plasma
55
348
1.95
3.48
4.6
3.7
mmol/l
2.3
2.4
0.31
49
311
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
29
144
2.27
3.46
14.5
14.5
mmol/l
24.1
25.0
0.86
29
144
(3025159) Blasts/100 leukocytes in Blood
18
71
2.76
3.45
4.2
6.4
%
0.0
0.0
—
6
19
(3044640) Blood type and Crossmatch panel - Blood
55
349
1.94
3.44
2.5
2.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
101
785
1.99
3.39
7.0
4.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
19
4.98
3.29
5.3
18.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
11
6.62
3.22
1.6
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
218
2.01
3.14
5.8
3.1
e6/l
1.0
0.8
0.20
25
122
(3035350) Ketones [Presence] in Urine by Test strip
78
567
1.83
3.12
5.8
3.8
estimate
0.0
0.0
0.00
19
90
(3045414) Leukocytes [Presence] in Urine
13
45
3.08
3.11
1.9
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
79
577
1.83
3.10
5.9
3.8
estimate
0.0
0.0
0.00
20
87
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
44
267
1.94
3.09
2.3
2.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
22
4.29
2.93
5.8
12.7
%
78.2
63.2
—
9
22
(3017181) Myelocytes/100 leukocytes in Blood
19
84
2.45
2.92
4.1
5.9
%
0.9
1.0
—
7
29
(3002173) Hemoglobin [Mass/volume] in Arterial blood
19
84
2.45
2.92
8.1
7.4
g/l
116.7
119.9
0.26
19
79
(3022948) Iron [Moles/volume] in Serum or Plasma
31
170
2.05
2.88
7.7
2.6
umol/l
12.4
13.8
0.65
31
160
(3012516) Albumin [Mass/volume] in Urine
42
257
1.90
2.86
6.6
3.1
mg/l
78.8
119.2
0.42
28
154
(3021601) Nitrite [Presence] in Urine by Test strip
77
570
1.76
2.79
8.1
5.3
estimate
0.0
0.0
0.00
19
93
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
72
523
1.76
2.79
4.4
3.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
6
8.57
2.77
4.6
2.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
6
8.57
2.77
1.6
1.0
umol/l
8.9
11.0
—
5
6
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
23
115
2.19
2.69
10.2
10.8
mmol/l
24.0
23.8
0.19
23
108
(3021440) Promyelocytes/100 leukocytes in Blood
17
75
2.44
2.62
4.5
6.3
%
0.0
0.2
—
6
24
(3024928) Oxygen saturation in Venous blood
9
25
3.77
2.62
7.0
11.6
—
—
—
0
0
(3024471) HLA-A [Type]
5
7
7.34
2.57
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
7
7.34
2.57
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
125
2.11
2.54
13.4
12.6
mmol/l
1.1
1.5
0.33
12
97
(3013115) Eosinophils [#/volume] in Blood
81
619
1.72
2.54
6.8
8.9
e9/l
0.2
0.2
0.05
75
548
(3027315) Oxygen [Partial pressure] in Blood
9
26
3.62
2.53
8.9
3.9
kpa
9.0
9.1
—
9
26
(3013290) Carbon dioxide [Partial pressure] in Blood
9
26
3.62
2.53
8.9
3.9
kpa
4.9
4.9
—
9
26
(3014007) Fractional oxyhemoglobin in Arterial blood
14
58
2.57
2.45
11.6
9.6
%
94.3
94.0
0.08
14
58
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
12
5.16
2.42
1.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
45
297
1.75
2.36
5.5
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
35
3.00
2.35
1.4
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
24
130
2.02
2.29
13.4
12.4
ph
7.4
7.4
—
6
11
(3016502) Oxygen saturation in Arterial blood
19
95
2.15
2.23
9.5
7.4
%
95.1
95.5
0.06
19
90
(3001604) Monocytes [#/volume] in Blood
77
596
1.64
2.18
6.8
8.4
e9/l
0.5
0.6
0.41
71
514
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
82
2.22
2.17
2.9
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
83
2.19
2.11
9.9
3.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
77
600
1.62
2.09
6.8
8.4
e9/l
0.0
0.0
0.85
71
520
(3011648) Oxygen content in Venous blood
6
15
4.12
2.06
7.7
17.6
%
11.0
11.7
—
6
15
(3013512) EKG study
40
266
1.70
2.01
3.5
3.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
33
2.84
1.97
2.0
2.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
36
234
1.72
1.96
4.4
4.4
umol/l
351.8
5028.9
1.07
31
206
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
16
3.86
1.95
1.0
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
20
108
1.99
1.93
9.1
7.0
kpa
5.1
5.3
0.42
20
101
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
12
54
2.33
1.79
8.1
9.4
mmol/l
23.9
24.5
0.24
12
49
(3019198) Lymphocytes [#/volume] in Blood
77
615
1.55
1.79
6.9
8.4
e9/l
1.8
2.1
1.51
70
549
(40758558) Short blood count panel - Blood
49
356
1.57
1.72
4.5
9.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
41
286
1.61
1.70
6.7
4.2
estimate
0.0
0.0
0.49
20
87
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
19
3.25
1.68
2.0
2.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
20
3.08
1.59
4.7
3.3
e9/l
3.8
4.7
—
6
20
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
20
3.08
1.59
4.7
3.3
%
53.2
58.0
—
6
20
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
55
416
1.52
1.59
5.9
3.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
17
94
1.92
1.55
1.5
1.4
u/ml
151.8
360.8
0.38
17
86
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
65
2.10
1.54
1.8
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
111
980
1.60
1.51
22.3
11.0
ml/min/173m2
77.9
88.3
3.34
99
777
(3044889) 12 lead EKG panel
85
714
1.47
1.43
3.3
3.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
54
417
1.47
1.39
6.7
8.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
300
1.51
1.36
4.5
3.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
39
0.00
1.36
0.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
99
867
1.47
1.27
3.9
3.8
pmol/l
14.8
14.5
0.44
92
791
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
117
1.72
1.25
1.5
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
71
1.91
1.24
2.2
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
116
1054
1.55
1.18
4.5
4.3
mu/l
1.7
1.9
0.93
106
959
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
35
0.00
1.17
0.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
20
2.55
1.16
1.2
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
191
0.54
1.15
2.4
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
53
422
1.41
1.12
1.9
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
49
385
1.42
1.12
4.4
6.6
inr
1.1
1.2
1.89
16
112
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
33
2.18
1.07
1.4
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
34
2.11
1.04
3.0
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
22
2.32
1.04
1.8
3.0
mg/l
12.2
11.0
—
5
22
(3003327) Ova and parasites identified in Stool by Light microscopy
10
53
1.95
1.04
2.4
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
18
116
1.63
1.02
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
69
583
1.36
1.00
14.2
11.1
e9/l
0.0
0.0
0.50
60
466
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
54
1.91
0.99
8.5
8.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
34
256
1.43
0.97
2.0
3.4
mg/l
1.3
0.8
0.81
27
204
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
32
0.00
0.96
0.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
37
1.94
0.95
1.9
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
10
55
1.88
0.94
10.6
6.3
mmol/l
23.9
25.2
—
10
48
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
15
95
1.65
0.91
2.3
4.7
ug/l
4.5
5.6
—
9
78
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
42
1.96
0.90
3.0
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
43
1.91
0.89
3.7
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
43
343
1.36
0.88
3.2
3.4
ng/l
27.7
30.6
0.12
31
212
(40760892) CBC W Ordered Manual Differential panel - Blood
32
243
1.41
0.87
6.8
5.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
44
1.86
0.87
4.5
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
44
1.86
0.87
2.6
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
31
1.97
0.85
4.2
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
46
1.78
0.84
1.5
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
45
366
1.33
0.81
2.4
1.8
pmol/l
94.9
97.6
0.11
21
185
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
125
1178
1.50
0.80
24.8
13.3
mg/l
27.6
22.0
0.82
103
884
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
33
1.85
0.80
1.0
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
20
141
1.49
0.80
2.5
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
80
707
1.30
0.79
8.6
12.2
e9/l
3.6
3.9
0.62
73
608
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
24
2.12
0.75
1.2
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
24
2.12
0.75
1.2
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
40
1.79
0.72
2.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
40
1.79
0.72
1.9
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
26
1.95
0.71
1.2
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
91
0.53
0.70
1.8
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
182
1.38
0.67
2.2
2.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
10
62
1.66
0.67
2.4
3.8
pmol/l
4.3
4.7
—
10
54
(40761511) CBC panel - Blood by Automated count
129
1233
1.50
0.65
19.1
11.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
105
0.55
0.64
1.3
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
50
1.63
0.62
9.4
4.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
30
1.69
0.62
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
51
1.60
0.61
1.1
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
44
371
1.27
0.60
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
53
1.54
0.59
1.1
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
123
0.63
0.57
1.3
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
36
1.69
0.57
1.2
1.3
—
3.3
—
0
6
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
37
1.65
0.56
1.2
1.2
—
15.2
—
0
7
(3009542) Hematocrit [Volume Fraction] of Blood
121
1151
1.34
0.56
20.2
15.3
%
38.8
39.7
0.63
99
940
(3000330) Specific gravity of Urine by Test strip
9
61
1.51
0.55
3.6
3.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
62
1.48
0.54
2.4
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
107
0.64
0.51
2.1
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
23
182
1.31
0.50
2.0
2.6
ug/g
335.5
104.5
0.46
16
148
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
45
1.58
0.49
1.9
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
40
341
1.24
0.49
1.2
1.5
u/ml
1.0
1.5
0.27
13
68
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
46
1.55
0.49
1.1
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
111
1.39
0.49
15.9
12.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
85
1.45
0.48
3.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
139
1.34
0.46
1.8
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
16
122
1.35
0.44
1.7
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
31
1.63
0.43
1.6
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
57
1.43
0.43
2.0
6.5
%
133.3
177.3
—
8
57
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
32
1.58
0.42
1.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
32
1.58
0.42
2.4
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
58
1.40
0.42
1.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
58
1.40
0.42
1.1
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
58
1.40
0.42
1.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
32
271
1.23
0.42
3.2
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
33
1.53
0.41
1.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.6
—
4.4
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
17
133
1.32
0.40
2.1
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
188
1.27
0.40
1.7
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3020891) Body temperature
5
35
1.44
0.39
2.8
6.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
35
1.44
0.39
1.4
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
111
1059
1.22
0.39
5.3
4.4
mmol/l
2.7
2.8
0.44
106
982
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
97
918
1.18
0.35
3.4
3.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
136
1.28
0.35
2.1
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
90
850
1.16
0.33
3.7
4.3
mm/h
11.2
10.1
0.31
85
780
(40768797) Stomach Pathology biopsy report
17
138
1.26
0.32
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
95
1.29
0.27
6.0
8.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
73
0.67
0.26
1.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
74
1.23
0.26
2.1
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
37
333
1.15
0.25
1.5
1.6
g/l
2.0
2.0
0.01
23
193
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
171
1.20
0.25
3.8
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
38
1.33
0.23
3.2
3.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
40
1.26
0.22
1.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
41
1.23
0.22
1.4
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
42
1.20
0.21
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
183
1.17
0.21
2.3
2.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
11
0.00
0.21
0.0
5.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
10
0.00
0.21
0.0
1.8
—
6.4
—
0
5
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
1.7
—
0
10
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
10
0.00
0.21
0.0
5.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
22
193
1.16
0.21
2.8
3.7
ng/l
695.0
365.2
0.20
15
132
(21494434) Karyotype in Bone marrow
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
14.4
—
1410.5
—
0
13
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
186
0.84
0.21
1.3
1.3
u/ml
5.8
12.3
—
10
69
(3045142) Bone marrow Pathology biopsy report
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
33
361
0.89
0.20
3.8
2.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
58
1.22
0.18
1.1
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
167
1.16
0.18
2.2
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
82
1.24
0.17
3.8
3.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
92
1.21
0.16
1.0
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
13
111
1.19
0.16
1.8
2.6
u/l
28.9
33.6
0.27
13
91
(3020961) Endomysium IgA Ab [Titer] in Serum
9
78
1.16
0.16
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
79
1.15
0.15
2.8
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
106
1034
1.10
0.14
4.3
3.8
mmol/l
5.5
5.8
2.85
98
948
(3000492) Spirometry study
12
103
1.18
0.14
1.1
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
43
1.17
0.10
1.0
1.2
—
—
—
0
0
(4035726)
10
87
1.16
0.09
1.3
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
48
1.04
0.09
3.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
54
1.12
0.09
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
56
1.07
0.09
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
63
0.79
0.08
2.0
1.2
—
—
—
0
0
(4010399)
8
75
1.07
0.07
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
78
1.03
0.07
1.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
141
0.91
0.06
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
228
1.06
0.05
3.3
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
174
1.04
0.00
4.1
4.2
%
24.9
21.4
—
10
86
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
335
1.02
0.00
1.9
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
153
0.98
0.00
2.8
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
10.1
—
0
6
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
5.7
—
1.2
—
0
6
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
6.8
—
0
6
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
58.4
—
0
7
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
55
0.91
0.00
1.4
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
8
0.00
0.00
0.0
1.0
—
197.3
—
0
8
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
230.9
—
0
9
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
1.1
—
0
8
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
132.1
—
0
7
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
1.2
—
0
7
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
144.9
—
0
5
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
12.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.8
—
41.2
—
0
5
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
16.6
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
5.7
—
1.2
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019225) pH of Specimen
8
81
0.99
0.00
3.7
5.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_KIDNEY and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_KIDNEY | 1.732 [1.2, 2.49] | 0.003 |
| Birth year | 0.99 [0.98, 1.0] | 0.035 |
During the follow-up period (1.1.1998 — 31.12.2019), 57 out of 696 males with Q17_OTHER_CONGEN_MALFO_KIDNEY died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_KIDNEY.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.409% |
| 5 | No data | 2.41% |
| 10 | No data | 5.811% |
| 15 | No data | 10.542% |
| 20 | No data | 17.333% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_KIDNEY – Other congenital malformations of kidney
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data